Evidence map›Paper›PMID 38771239›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2024

In vivo neuropil density from anatomical MRI and machine learning.

Adil Akif, Lawrence Staib, Peter Herman, Douglas L Rothman, Yuguo Yu, Fahmeed Hyder

Abstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adil AkifDepartment of Biomedical Engineering, Yale University, 55 Prospect St, New Haven, CT 06511, United States.
Lawrence StaibDepartment of Biomedical Engineering, Yale University, 55 Prospect St, New Haven, CT 06511, United States.
Peter HermanDepartment of Radiology and Biomedical Imaging, Yale University, 300 Cedar St, New Haven, CT 06520, United States.
Douglas L RothmanDepartment of Biomedical Engineering, Yale University, 55 Prospect St, New Haven, CT 06511, United States.
Yuguo YuResearch Institute of Intelligent and Complex Systems, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institute of Science and Technology for Brain-Inspired Intelligence, 220 Handen Road, Shanghai, 200032, China.
Fahmeed HyderDepartment of Biomedical Engineering, Yale University, 55 Prospect St, New Haven, CT 06511, United States.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Energetics of Neuronal Populations by fMRIR01MH067528 · NIMH · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2002 to 2021
$5.9M
MRS validation of computational metabolic modeling of human brain function to determine energetic disruptions underlying fMRI-derived functional connectivity in degenerative or psychiatric disordersR01NS100106 · NINDS · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED, ROTHMAN, DOUGLAS LYLE · 2017 to 2021
$959k
Metabolic and neuromodulatory basis of altered activated and deactivated cortical areas in healthy human agingR56AG079086 · NIA · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED, ROTHMAN, DOUGLAS LYLE · 2022 to 2022
$657k
AbbVieAlzheimer's AssociationAlzheimer's Disease Neuroimaging InitiativeAlzheimer's Drug Discovery FoundationAraclon BiotechBioClinica, IncBiogenBristol-Myers Squibb CompanyCereSpir, Inc.CogstateDepartment of Defense W81XWH-12-2-0012DOD ADNIEisai Inc.Elan Pharmaceuticals, Inc.Eli Lilly and CompanyEuroImmunF. Hoffmann-La Roche LtdNCATS NIH HHS UL1 TR001863NIA NIH HHS R56 AG079086NIA NIH HHS U01 AG024904NIBIB NIH HHSNIDDK NIH HHS P30 DK045735NIH HHS R56 AG079086NIH HHS U01 AG024904NIMH NIH HHS R01 MH067528NINDS NIH HHS R01 NS100106
6 · The paper itself

Abstract

Brain energy budgets specify metabolic costs emerging from underlying mechanisms of cellular and synaptic activities. While current bottom-up energy budgets use prototypical values of cellular density and synaptic density, predicting metabolism from a person's individualized neuropil density would be ideal. We hypothesize that in vivo neuropil density can be derived from magnetic resonance imaging (MRI) data, consisting of longitudinal relaxation (T1) MRI for gray/white matter distinction and diffusion MRI for tissue cellularity (apparent diffusion coefficient, ADC) and axon directionality (fractional anisotropy, FA). We present a machine learning algorithm that predicts neuropil density from in vivo MRI scans, where ex vivo Merker staining and in vivo synaptic vesicle glycoprotein 2A Positron Emission Tomography (SV2A-PET) images were reference standards for cellular and synaptic density, respectively. We used Gaussian-smoothed T1/ADC/FA data from 10 healthy subjects to train an artificial neural network, subsequently used to predict cellular and synaptic density for 54 test subjects. While excellent histogram overlaps were observed both for synaptic density (0.93) and cellular density (0.85) maps across all subjects, the lower spatial correlations both for synaptic density (0.89) and cellular density (0.58) maps are suggestive of individualized predictions. This proof-of-concept artificial neural network may pave the way for individualized energy atlas prediction, enabling microscopic interpretations of functional neuroimaging data.

Indexed as

BrainMachine LearningMagnetic Resonance ImagingNeuropilAdultFemaleGray MatterHumansImage Processing, Computer-AssistedMaleMiddle AgedNeural Networks, ComputerPositron-Emission TomographyWhite MatterYoung AdultAerobic glycolysisastrocytebrain energeticsglucoseglutamatehuman brain connectomelactate, spiking rate

Identifiers

PMID38771239
PMCPMC11107380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.